Veritas Clinical Specialties is located in Northeast Kansas. The center is 5000 square feet of dedicated research space. There are several departments within the center including regulatory, quality assurance, recruitment & retention, education & training, and patient screening.

Currently, Veritas is seeking our Phase I, II, III and IV clinical research trials as well as device trials that can be conducted in Northeast Kansas and the surrounding areas. The primary goal of Veritas is to advance the development of cutting edge pharmaceutical and device treatments, in the most ethical manner, to benefit our patients and the community. This is the job of our compassionate and experienced research team at the center. We not only have a dedicated internal team of professionals but are also fortunate enough to work with top notch area sub-specialists.

Capabilities

Indications:

• ADHD
• Asthma
• COPD
• Depression
• Diabetes
• Hyperlipidemia
• Insomnia
• Narcolepsy
• Pulmonary Hypertension
• Renal Disease, dialysis
• Restless Leg Syndrome
• Sleep Disorders

Pediatrics:

• ADHD
• Allergies
• Asthma
• Narcolepsy
• Sleep

Hospital Studies:

• Deep Vein Thrombosis
• Device Studies
• Pneumonia
• Pulmonary Embolism
• Sedation
• Sepsis
• Skin and Soft tissue infections

Interventional Trials:

• Asthma
• COPD

Sponsor History

Pharmaceutical Companies:

• Altana
• Astra Zeneca
• Cephalon
• Dey
• Epix
• Eli Lilly
• Genetech
• Glaxo SmithKline
• Kyowa
• Merck
• Minster
• Ono
• Sanofi-Aventis
• Shering-Plough
• Sepracor
• Shire
• Wyeth
• UBC

Device Companies:

• Aeris
• Asthmatx
• Broncus Technologies
• Emphasys Medical

Clinical Research Organizations (CRO’s):

• Covance
• I3
• ICON
• Parexcel
• Pharmanet
• PRA Intenational
• Quintiles

Central Institutional Review Boards (IRB’s):

• BioMed
• Chesapeake
• Coast IRB
• Copernicus Group
• Integra Review IRB
• Quorum
• WIRB
• Shulman Assoc.
• Sterling
• Independent

Veritas is headquartered in a beautiful new state of the art facility offering over 5,000 square feet of dedicated research space. Veritas recognizes the importance of the continued cooperation of our subject volunteers, and makes every effort to make their visits enjoyable and stress free. With the comfort and satisfaction of our subjects in mind, we offer an amenity rich day room suitable for study visits of longer duration. Our day room features a comfortable and luxurious living area which offers privacy as well as an entertainment center and dining facilities. For the added convenience of our guests we also provide telephone and high speed internet access.

In addition to the subject volunteer day room, our facility features six professionally decorated suites suitable for overnight Phase I studies. Our Phase I and sequestering capabilities include both inpatient and outpatient services including significant pharmacokinetic testing, 24/7 patient monitoring, and around-the-clock blood draws. As needed, patients can be sequestered and monitored to ensure compliance with study-related restrictions such as food and beverage intake as well as smoking, exercise and the like. Sequestered patients are monitored around the clock by our multi-disciplinary clinical team. Our luxurious suites are handicap accessible and fully accredited for sleep studies which are performed by our full-time RPSGT’s.

The following is a list of some of the resources offered at the Veritas facility:

• 6 exam rooms
• 6 Bed Accredited Sleep Lab with full time RPSGT’s on staff
• Day room for patients – For 12 hour and 24 hour trials
• A private monitor conference room with high speed internet access
• Regulation refrigerator and -20 freezer
• 2 centrifuges
• Blood laboratory
• State of the art Pulmonary Function and Exercise Lab
• Portable Pulmonary Function Testing
• Echocardiogram Machine
• EKG Machine
• Climate Controlled, Secure Record Storage Room
• FDA compliant investigational product storage room
• Two full service emergency departments adjacent to the Veritas campus

Research Team

William Leeds, DO, FCCP, Medical Director

Osman Malik, MD, Investigator

Vlad Dimitriu, MD Investigator

Anthony Bram, PhD, Investigator

Laura Ludlow, PA-C, Sub-Investigator

Glen Fair, MSM, CRT, Director of Research

Suzanne Nicklin, Assistant Director of Clinical Research

James Cain, Clinical Research Coordinator

Dusty Griggs, Clinical Research Coordinator

Susan Kaspar, Regulatory Affairs

Ted Jilek, Director of Pulmonary Function Testing

Dusty Kuhn, Research Assistant

Casey Leeds, Research Assistant

Trial Experience

Our seasoned team of research professionals at Veritas has extensive experience in both pharmaceutical and device trials. We have successfully completed studies for numerous major pharmaceutical companies. In addition, our experience has enabled us to confidently lead pivotal studies for start up companies. Our work ethic and attention to detail has earned us relationships of trust and mutual respect of our sponsors as well as the many CRO’s and IRB’s with whom we work.

Our philosophy at Veritas is to be selective in the studies that we conduct. This allows us to devote the time and resources necessary to achieve full enrollment and quality data that is in strict regulatory compliance. We continually invest in the education and technology necessary to conduct quality research. We are constantly striving for improvement and are proud of our track record.

Practice
Community
Physician Referrals

Veritas currently uses central or local IRB's.

For more information, please contact:

Glen Fair
Director of Research
Veritas Clinical Specialties
515 SW Horne Street
Topeka, KS 66606 USA
Phone: 785-354-0735
Fax: 785-354-0736
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on June 20, 2008